ArticleACS medicinal chemistry letters2024

Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology.

Yam B Poudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.